AL OZONOFF
Profiles

AL J OZONOFF, PhD, CPPS

Adjunct Associate Professor, Biostatistics - Boston University School of Public Health

(617) 638-5160
aozonoff@bu.edu
Crosstown Center
View Full Profile at BUMC

Biography

Dr. Ozonoff is Associate Professor of Pediatrics at Harvard Medical School, faculty scientist within the Division of Infectious Diseases at Boston Children's Hospital, and Adjunct Associate Professor of Biostatistics at the Boston University School of Public Health. His scientific research is focused on development and application of surveillance methods in the fields of public health, healthcare quality, and patient safety. He is Principal Investigator of a 5-year project funded by the Agency for Healthcare Research and Quality (AHRQ), "Patient safety surveillance using machine learning and free text clinical notes" (R01 HS026246-01A1) and leads the Data Management Core for the Precision Vaccines Program at BCH. He holds advisory and consulting roles with state agencies including the Massachusetts Cancer Registry, the Massachusetts Office of Population Health, and the Massachusetts Bureau of Environmental Health.

Education

  • University of California, Santa Barbara, PhD Field of Study: Mathematics
  • University of California, Santa Barbara, MA Field of Study: Mathematics
  • Boston University, BA Field of Study: Mathematics

Websites

Publications

  • Published on 8/15/2022

    Morrocchi E, Pighi C, Pascucci GR, Cotugno N, Medri C, Amodio D, Colagrossi L, Ruggiero A, Manno EC, Casamento Tumeo C, Bernardi S, Smolen KK, Perno CF, Ozonoff A, Rossi P, Levy O, Palma P. Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity. Clin Infect Dis. 2022 Aug 15; 75(Supplement_1):S51-S60. PMID: 35738253.

     Read At: PubMed
  • Published on 8/15/2022

    Top KA, Chen RT, Levy O, Ozonoff A, Carleton B, Crawford NW, Creech CB, Kochhar S, Poland GA, Gutu K, Cutland CL. Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services. Clin Infect Dis. 2022 Aug 15; 75(Supplement_1):S11-S17. PMID: 35680552.

     Read At: PubMed
  • Published on 8/15/2022

    Nanishi E, Angelidou A, Rotman C, Dowling DJ, Levy O, Ozonoff A. Precision Vaccine Adjuvants for Older Adults: A Scoping Review. Clin Infect Dis. 2022 Aug 15; 75(Supplement_1):S72-S80. PMID: 35439286.

     Read At: PubMed
  • Published on 7/11/2022

    Chew K, Lee B, van Haren SD, Nanishi E, O'Meara T, Splaine JB, DeLeon M, Soni D, Seo HS, Dhe-Paganon S, Ozonoff A, Smith JA, Levy O, Dowling DJ. Adjuvant Discovery via a High Throughput Screen using Human Primary Mononuclear Cells. bioRxiv. 2022 Jul 11. PMID: 35860217.

     Read At: PubMed
  • Published on 5/3/2022

    Diray-Arce J, Angelidou A, Jensen KJ, Conti MG, Kelly RS, Pettengill MA, Liu M, van Haren SD, McCulloch SD, Michelloti G, Idoko O, Kollmann TR, Kampmann B, Steen H, Ozonoff A, Lasky-Su J, Benn CS, Levy O. Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro. Cell Rep. 2022 05 03; 39(5):110772. PMID: 35508141.

     Read At: PubMed
  • Published on 3/31/2022

    Ruggiero A, Pascucci GR, Cotugno N, Domínguez-Rodríguez S, Rinaldi S, Tagarro A, Rojo P, Foster C, Bamford A, De Rossi A, Nastouli E, Klein N, Morrocchi E, Fatou B, Smolen KK, Ozonoff A, Di Pastena M, Luzuriaga K, Steen H, Giaquinto C, Goulder P, Rossi P, Levy O, Pahwa S, Palma P. Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy. Front Immunol. 2022; 13:860418. PMID: 35432380.

     Read At: PubMed
  • Published on 3/3/2022

    Nanishi E, Levy O, Ozonoff A. Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review. Hum Vaccin Immunother. 2022 Nov 30; 18(5):2045857. PMID: 35240940.

     Read At: PubMed
  • Published on 1/26/2022

    Nanishi E, Borriello F, O'Meara TR, McGrath ME, Saito Y, Haupt RE, Seo HS, van Haren SD, Cavazzoni CB, Brook B, Barman S, Chen J, Diray-Arce J, Doss-Gollin S, De Leon M, Prevost-Reilly A, Chew K, Menon M, Song K, Xu AZ, Caradonna TM, Feldman J, Hauser BM, Schmidt AG, Sherman AC, Baden LR, Ernst RK, Dillen C, Weston SM, Johnson RM, Hammond HL, Mayer R, Burke A, Bottazzi ME, Hotez PJ, Strych U, Chang A, Yu J, Sage PT, Barouch DH, Dhe-Paganon S, Zanoni I, Ozonoff A, Frieman MB, Levy O, Dowling DJ. An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice. Sci Transl Med. 2022 Jan 26; 14(629):eabj5305. PMID: 34783582.

     Read At: PubMed
  • Published on 12/28/2021

    Milliren CE, Bailey G, Graham DA, Ozonoff A. Relationships Between Pediatric Safety Indicators Across a National Sample of Pediatric Hospitals: Dispelling the Myth of the "Safest" Hospital. J Patient Saf. 2022 Jun 01; 18(4):e741-e746. PMID: 35617599.

     Read At: PubMed
  • Published on 12/1/2021

    Al-Samkari H, Ozonoff A, Landschaft A, Kimia R, Harper MB, Croteau SE, Kimia AA. Utility of Blood Cultures and Empiric Antibiotics in Febrile Pediatric Hemophilia Patients With Central Venous Access Devices. Pediatr Emerg Care. 2021 Dec 01; 37(12):e1531-e1534. PMID: 32349076.

     Read At: PubMed

View 228 more publications:View Full Profile at BUMC

View all profiles